After 14 days of adjustment, all three A-share indexes closed up on the 15th. Among them, the gem index rose more than 3% to 2800 points.
As of the closing, the stock index rose 0.50% to close at 3446.09, with a turnover of 341.64 billion yuan (RMB, the same below); The Shenzhen Component Index rose 1.69% to close at 13345.63 points, with a turnover of 485.86 billion yuan; The gem index rose 3.09% to close at 2816.44 points, with a turnover of 184.99 billion yuan.
On the disk, the medical sector, semiconductor and components, education and new energy sectors strengthened. Tourism hotels, airport shipping, real estate development and coal sectors fell. Stocks in the three cities rose or fell by half, with nearly 70 trading stocks.
It is worth noting that after a period of depression, pharmaceutical stocks finally rebounded. On the same day, the medical service sector led the rise, while the medical device sector followed. Lu bole, chief strategist of Baida asset management in Switzerland, said that after experiencing a challenging 2021 and entering the year of the tiger, the prospect of China’s stock market is improving. The valuation of stocks in the healthcare sector seems particularly attractive.
“China’s stock market is looking better in the year of the tiger. With the global economy accelerating again under China’s leadership and strong growth of corporate profits, the stock market has a promising prospect after the sharp sell-off in January. Due to the attractive valuation, we upgraded the stock rating to overweight. Compared with the past adjustment, the multi asset risk appetite index is still in a positive range.”
However, the Central China Securities Co.Ltd(601375) research team also reminded that some institutions are still changing positions and shares, and the market will still face certain fluctuations in the future. It is expected that the short-term slight correction of the Shanghai index is more likely, and the short-term slight shock of the gem is more likely. It is suggested to wait and see for a while in the short term and continue to pay attention to the investment opportunities of undervalued blue chips in the middle line. (end)
